Last reviewed · How we verify

NCT06576947

Virtual Reality in the Treatment of Pelvic Floor Dysfunction in Women With Multiple Sclerosis

Not yet recruiting NA Last updated 29 August 2024
What this trial tests

NA trial testing Virtual reality in Multiple Sclerosis in 45 participants. Not yet recruiting.

Timeline
1 September 2024
Primary endpoint
1 July 2025
1 December 2025

Quick facts

Lead sponsorUniversidad de Almeria
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment45
Start date1 September 2024
Primary completion1 July 2025
Estimated completion1 December 2025

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Almeria

Who can join

Adults 18 to 65, female only, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the current randomized clinical trial was to compare the effectiveness of virtual reality versus posterior tibial nerve stimulation on the improvement of pelvic floor dysfunctions in women with multiple sclerosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Virtual reality

Trials testing the same drug.

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Universidad de Almeria trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06576947.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing